Physician profile
Jack W Lenox
NPI 1508979345
$207,884.96
in general payments reported to CMS, 2019-2025
28 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $34K · 2021: $94K · 2022: $28K · 2023: $4,473 · 2024: $9,419 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $1,336 · Travel and Lodging: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Food and Beverage | $1,336.22 |
| Travel and Lodging | $831.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $166,621.62 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $38,787.56 | 2019-2022 | |
| Astellas Pharma US INC | $260.18 | 2021-2023 | Veozah |
| Coopersurgical, INC. | $215.71 | 2021-2023 | Advincula Delineator Uterine Manipulator |
| Therapeuticsmd, INC. | $202.14 | 2021-2022 | |
| Myovant Sciences INC. | $194.56 | 2021-2022 | |
| Hologic Sales and Service, LLC | $187.68 | 2021-2024 | Acessa Provu System, Novasure |
| Gynesonics, INC. | $155.83 | 2022 | |
| Pfizer INC. | $152.75 | 2021-2022 | |
| Exeltis, USA INC. | $128.28 | 2021-2022 | |
| Baxter Healthcare | $107.15 | 2025 | Floseal |
| Agile Therapeutics, INC. | $100.51 | 2021-2022 | |
| Novo Nordisk INC | $76.18 | 2021 | |
| Aspira Women'S Health INC | $73.23 | 2021-2022 | |
| Organon LLC | $72.85 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $71.94 | 2019-2024 | Bridion |
| Biohaven Pharmaceuticals, INC. | $71.91 | 2021 | |
| Avion Pharmaceuticals | $67.28 | 2021-2022 | |
| Amgen INC. | $66.48 | 2021-2022 | |
| Smith+Nephew, INC. | $57.34 | 2021-2022 | |
| Arteriocyte Medical Systems, INC. | $43.26 | 2022 | |
| Conmed Corporation | $35.71 | 2025 | Airseal |
| Biohaven Pharmaceutical Holding Company LTD. | $33.54 | 2022 | |
| Minerva Surgical, INC | $29.37 | 2022 | |
| Channel Medsystems, INC. | $20.66 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.85 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.77 | 2023 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Lenox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.